Impaired survival associated with low CDK9 expression, may be correlated with increased MCL1 expression (see Figure S1D) since increased MCL1 expression has been demonstrated to be associated with CDK9 drug resistance in leukemia [37], although this has to be further evaluated in a larger cohort of patients. Here, CDK9 is linked to leukemia.